Skip to main content
. 2016 Mar 3;2016(3):CD005008. doi: 10.1002/14651858.CD005008.pub4

3.1. Analysis.

3.1

Comparison 3: Liposomal doxorubicin (Caelyx) peak dose 25 mg/m2 versus 50 mg/m2, Outcome 1: Response rate (defined as objective palliative tumour response (i.e. decrease in PSA levels of >= 50%))